Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the Treatment of Multiple Myeloma
Conditions: CD38 Positive; Plasma Cell Myeloma Interventions: Biological: Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10; Drug: Melphalan; Procedure: Peripheral Blood Stem Cell Transplantation Sponsors: Fred Hutchinson Cancer Research Center; National Cancer Institute (NCI); National Institutes of Health (NIH) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Chemotherapy | Myeloma | Research | Stem Cell Therapy | Stem Cells | Transplants